Almac integrates drug development services into new US headquarters
26 Oct 2010
Northern Island-based Almac has moved its Clinical
Technologies division into the Almac Group’s new North American
Headquarters.
The firm has now completed the first phase of relocating employees
from three business units to the new 240,000 square feet
state-of-the-art integrated drug development facility.
On 11 October, Almac’s technology business unit joined employees
from its analytical testing and clinical supplies units. Over the
course of the next two months, Almac will move the remainder of its
clinical supplies operations currently located in Audubon, PA, into
the integrated drug development facility in Souderton, PA.
Jim Murphy, President of Almac’s clinical technologies business
unit, said, “Our IT, Quality Assurance, senior management team, and
other key personnel worked in unison to ensure that all of our
systems were tested and met the highest standards before we moved
into the new facility. The transition team’s meticulous planning
enabled us to avoid any downtime on client studies outside of our
normal maintenance windows. I am delighted to announce that
everything went as planned with this perfectly executed transition.”
The move of three Almac business units to a new North American
Headquarters is part of the Almac Group’s integrated services
solutions strategy. The new facility was planned to deliver a
full-service, integrated drug supply management and technology
solution to biopharmaceutical clients.
Dr Joseph Bedford, Director of Marketing at Almac’s Clinical
Technologies business unit commented: “The biopharmaceutical
industry is making great strides to streamline drug development and
bring efficiencies to clinical trials. Our new North American
Headquarters allows Almac to deliver an integrated clinical
supplies, analytical testing, and clinical technologies offering to
sponsors that is unparalleled in our industry.
"Working with integrated teams of drug supply management and
technology specialists at Almac, our clients will benefit from the
combined insights of experienced professionals who deliver
efficiencies in the clinical supplies chain that no other firm can
match.”